Literature DB >> 27501296

Deciphering Cell-to-Cell Communication in Acquisition of Cancer Traits: Extracellular Membrane Vesicles Are Regulators of Tissue Biomechanics.

Deep Pokharel1, Philip Wijesinghe2, Vici Oenarto1, Jamie F Lu1, David D Sampson2,3, Brendan F Kennedy2,4, Vincent P Wallace5, Mary Bebawy1.   

Abstract

Deciphering the role of cell-to-cell communication in acquisition of cancer traits such as metastasis is one of the key challenges of integrative biology and clinical oncology. In this context, extracellular vesicles (EVs) are important vectors in cell-to-cell communication and serve as conduits in the transfer of cellular constituents required for cell function and for the establishment of cellular phenotypes. In the case of malignancy, they have been shown to support the acquisition of common traits defined as constituting the hallmarks of cancer. Cellular biophysics has contributed to our understanding of some of these central traits with changes in tissue biomechanics reflective of cell state. Indeed, much is known about stiffness of the tissue scaffold in the context of cell invasion and migration. This article advances this knowledge frontier by showing for the first time that EVs are mediators of tissue biomechanical properties and, importantly, demonstrates a link between the acquisition of cancer multidrug resistance and increased tissue stiffness of the malignant mass. The methodology used in the study employed optical coherence elastography and atomic force microscopy on breast cancer cell monolayers and tumor spheroids. Specifically, we show here that the acquired changes in tissue stiffness can be attributed to the intracellular transfer of a protein complex comprising ezrin, radixin, moesin, CD44, and P-glycoprotein. This has important implications in facilitating mechano-transduced signaling cascades that regulate the acquisition of cancer traits, such as invasion and metastasis. Finally, this study also introduces novel targets and strategies for diagnostic and therapeutic innovation in oncology, with a view to prevention of metastatic spread and personalized medicine in cancer treatment.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27501296     DOI: 10.1089/omi.2016.0072

Source DB:  PubMed          Journal:  OMICS        ISSN: 1536-2310


  7 in total

Review 1.  Optical coherence elastography - OCT at work in tissue biomechanics [Invited].

Authors:  Kirill V Larin; David D Sampson
Journal:  Biomed Opt Express       Date:  2017-01-27       Impact factor: 3.732

Review 2.  Therapeutic prospects of microRNAs in cancer treatment through nanotechnology.

Authors:  Rajendra Awasthi; Michael John Rathbone; Philip Michael Hansbro; Mary Bebawy; Kamal Dua
Journal:  Drug Deliv Transl Res       Date:  2018-02       Impact factor: 4.617

3.  Extracellular Vesicles in Chemoresistance.

Authors:  Gabriele De Rubis; Mary Bebawy
Journal:  Subcell Biochem       Date:  2021

4.  A novel mechanism governing the transcriptional regulation of ABC transporters in MDR cancer cells.

Authors:  Jamie F Lu; Deep Pokharel; Mary Bebawy
Journal:  Drug Deliv Transl Res       Date:  2017-04       Impact factor: 4.617

Review 5.  Proteins regulating the intercellular transfer and function of P-glycoprotein in multidrug-resistant cancer.

Authors:  Deep Pokharel; Ariane Roseblade; Vici Oenarto; Jamie F Lu; Mary Bebawy
Journal:  Ecancermedicalscience       Date:  2017-09-18

Review 6.  Application of Mesenchymal Stem Cells for Therapeutic Agent Delivery in Anti-tumor Treatment.

Authors:  Daria S Chulpanova; Kristina V Kitaeva; Leysan G Tazetdinova; Victoria James; Albert A Rizvanov; Valeriya V Solovyeva
Journal:  Front Pharmacol       Date:  2018-03-20       Impact factor: 5.810

7.  Ca2+ mediates extracellular vesicle biogenesis through alternate pathways in malignancy.

Authors:  Jack Taylor; Iman Azimi; Gregory Monteith; Mary Bebawy
Journal:  J Extracell Vesicles       Date:  2020-03-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.